» Articles » PMID: 3055962

Immunobiology of IgA

Overview
Journal Am J Kidney Dis
Specialty Nephrology
Date 1988 Nov 1
PMID 3055962
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

In humans, IgA is produced in quantities larger than those of all other immunoglobulin isotypes combined. In comparison with immunoglobulin of other isotypes, human IgA displays a unique heterogeneity of its molecular forms with a characteristic distribution in various body fluids. Serum IgA is represented by predominantly monomeric molecules of the IgA1 subclass and is produced mainly in the bone marrow, while in external secretions most of the IgA, produced locally in mucosal tissues, occurs in the polymeric configuration with a relatively increased proportion of IgA2 molecules. Cells that produce monomeric or polymeric IgA and IgA1 or IgA2 molecules are characteristically distributed in various lymphoid and nonlymphoid tissues. The differential interactions of monomeric and polymeric IgA molecules with various cells lead to their selective distribution in body fluids and to differences in the effector functions. Contrary to immunoglobulins of other isotypes, IgA participates in the disposal of antigens by mechanisms mostly devoid of inflammatory consequences. Various modes of immunization can induce an immune response in the systemic and/or secretory IgA compartments. Although most of the total serum IgA is momomeric, recent studies indicate that specific serum IgA antibodies induced by either mucosal or systemic immunizations with microbial antigens appear first in the polymeric form. Thus, cautious immunochemical analyses of IgA antibodies in systemic and secretory compartments with respect to their kinetics of appearance, monomeric and polymeric forms, and subclass may elucidate their tissue origin and character of the antigen involved in their induction.

Citing Articles

Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don't Know.

Ohyama Y, Renfrow M, Novak J, Takahashi K J Clin Med. 2021; 10(16).

PMID: 34441764 PMC: 8396900. DOI: 10.3390/jcm10163467.


Immunological Outcomes of Allergen-Specific Immunotherapy in Food Allergy.

Schoos A, Bullens D, Chawes B, Costa J, De Vlieger L, DunnGalvin A Front Immunol. 2020; 11:568598.

PMID: 33224138 PMC: 7670865. DOI: 10.3389/fimmu.2020.568598.


Antibody Responses to SARS-CoV-2: Let's Stick to Known Knowns.

Baumgarth N, Nikolich-Zugich J, Lee F, Bhattacharya D J Immunol. 2020; 205(9):2342-2350.

PMID: 32887754 PMC: 7578055. DOI: 10.4049/jimmunol.2000839.


Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.

Franc V, Rehulka P, Raus M, Stulik J, Novak J, Renfrow M J Proteomics. 2013; 92:299-312.

PMID: 23891555 PMC: 3984899. DOI: 10.1016/j.jprot.2013.07.013.


Transglutaminase is essential for IgA nephropathy development acting through IgA receptors.

Berthelot L, Papista C, Maciel T, Biarnes-Pelicot M, Tissandie E, Wang P J Exp Med. 2012; 209(4):793-806.

PMID: 22451718 PMC: 3328362. DOI: 10.1084/jem.20112005.